You typically do not need your own Wholesale Dealer's Authorisation (WDA) to start a UK telehealth brand. WDA is required for entities that procure, hold, and supply medicines in bulk — typically wholesalers and certain manufacturers. UK telehealth brands that partner with a GPhC-registered pharmacy access medicines through the partner's normal supply chain. This piece walks through when WDA is and is not required.
What a WDA is and who needs one
A Wholesale Dealer's Authorisation is an MHRA-issued licence permitting the holder to procure, hold, and supply licensed medicines in bulk to other businesses (pharmacies, hospitals, clinics). WDA holders must comply with Good Distribution Practice (GDP), maintain a Responsible Person, and operate appropriate storage and quality systems.
Entities that need a WDA: wholesalers selling to pharmacies, brokers, and some hospital pharmacies. Entities that typically do not: retail pharmacies dispensing to patients (they purchase from WDA-licensed wholesalers but do not themselves require WDA for their own purchases), and telehealth brands that operate via dispensing partners.
The telehealth brand supply chain
A UK telehealth brand typically does not procure, hold, or supply medicines directly. The dispensing pharmacy (own or partnered) purchases medicines from WDA-licensed wholesalers, holds them in stock, and dispenses to patients under prescription. The brand sits commercially upstream of this supply chain but does not handle medicines itself.
If the brand handles medicines — for example, by holding stock or moving it between locations — WDA may become relevant. But standard brand operation (marketing, consultation, patient experience) does not involve medicines handling and does not require WDA.
When WDA might be needed
Specific situations where WDA might be required: a telehealth brand that imports medicines from overseas suppliers for distribution to UK pharmacies (importation plus onward supply triggers WDA), a brand that holds stock in its own warehouse before transfer to a dispensing partner (depending on legal title arrangements), or a brand that operates multiple owned pharmacy locations and moves stock between them (intra-company supply).
These are atypical operational patterns. Most UK telehealth brands launched in 2024-2026 do not encounter WDA requirements because the dispensing partnership model handles supply through the partner's existing arrangements.
Obtaining a WDA — what it involves
WDA application typically takes 6-12 months from submission to grant. Requirements include: appropriate premises with GDP-compliant storage, a Responsible Person (named individual accountable for compliance), documented quality systems, and ongoing post-grant compliance and inspection.
It is a substantial regulatory project. For most UK telehealth brands, it is the wrong route to operate — partnership with a dispensing pharmacy gives access to WDA-licensed supply through the partner without the brand needing its own WDA.
How PExpo handles the supply chain
PExpo operates a GPhC-registered dispensing pharmacy that procures medicines from WDA-licensed UK wholesalers under proper GDP-compliant supply arrangements. Brand customers do not need their own WDA — the supply chain operates entirely through PExpo's pharmacy operation.
See our brand model page for the operational scope and our pricing page for the commercial structure.
Most UK telehealth brands do not need their own WDA. The dispensing pharmacy (own or partnered) handles medicines through its own WDA-licensed supply chain. Brand operations sit upstream of medicines handling.
WDA application takes 6-12 months and substantial infrastructure. For most UK telehealth brands, partnership with a dispensing pharmacy is the right route, not building a WDA-licensed wholesale operation.
You typically do not need a Wholesale Dealer's Authorisation to launch a UK telehealth brand. The dispensing partner handles medicines through its own WDA-licensed supply chain. WDA becomes relevant only if you handle medicines directly — importation, warehousing, intra-company supply. See our brand model page for the partnership route and our pricing page for the commercial structure.
Frequently asked questions
Can I import medicines from overseas without a WDA?
Importation of medicines for onward supply typically requires WDA. For patient-specific Specials regime supply, different rules apply. For most UK telehealth brand operations, importation is not needed because medicines are sourced through UK-licensed wholesalers via the dispensing partner.
Does the dispensing pharmacy need a WDA?
Retail pharmacies dispensing to patients typically do not require WDA themselves — they purchase from WDA-licensed wholesalers. WDA is for entities supplying medicines to other businesses, not to end patients.
Does PExpo hold a WDA?
PExpo's dispensing pharmacy operates with appropriate MHRA authorisations for its activities. WDA-equivalent operations sit with PExpo's wholesale supply partners. See our brand model page for the operational scope.
